Titan Pharmaceuticals Inc. buy melinda
Start price
23.02.18
/
50%
€172.10
Target price
22.03.18
€194.83
Performance (%)
22.58%
End price
22.03.18
€210.97
Summary
This prediction ended on 22.03.18 with a price of €210.97. The BUY prediction by melinda finished with a performance of 22.58%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Titan Pharmaceuticals Inc. | - | - | - | - |
iShares Core DAX® | -3.935% | -2.628% | 10.013% | 11.951% |
iShares Nasdaq 100 | -3.608% | -9.283% | 20.668% | 35.711% |
iShares Nikkei 225® | -4.513% | -6.951% | 5.241% | 2.602% |
iShares S&P 500 | -2.607% | -4.402% | 20.177% | 37.820% |
Comments by melinda for this prediction
In the thread Titan Pharmaceuticals Inc diskutieren
Pharma SecteurProduits
Titan Pharmaceuticals, Inc. ist ein biopharmazeutisches Unternehmen, die sich in Entwicklung qui proprietäre Therapeutika in erster Linie für die Behandlung von medizinischen disorders.Its Produkte Probuphine umfassen, bietet die Blutspiegel von Buprenorphin nicht-fluktuierende; Ropinirol Implantat dopaminergen Bietet qui ...
(Zielkurs erreicht)
Stopped prediction by melinda for Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€4.17
24.10.20
24.10.20
€9.00
04.11.21
04.11.21
-65.11%
05.11.21
05.11.21
Titan Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€39.68
05.10.18
05.10.18
€81.18
22.10.18
22.10.18
44.72%
22.10.18
22.10.18
Titan Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€276.01
25.08.17
25.08.17
€568.26
27.12.17
27.12.17
-20.59%
27.12.17
27.12.17
Titan Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€891.36
08.07.16
08.07.16
€1,298.9
09.01.17
09.01.17
-18.94%
09.01.17
09.01.17